Nuveen LLC purchased a new stake in UiPath, Inc. (NYSE:PATH - Free Report) during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund purchased 1,019,691 shares of the company's stock, valued at approximately $10,503,000. Nuveen LLC owned approximately 0.18% of UiPath as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Invesco Ltd. boosted its position in UiPath by 18.8% in the first quarter. Invesco Ltd. now owns 454,849 shares of the company's stock valued at $4,685,000 after buying an additional 72,049 shares in the last quarter. Covestor Ltd lifted its position in shares of UiPath by 13.1% during the first quarter. Covestor Ltd now owns 11,070 shares of the company's stock worth $114,000 after purchasing an additional 1,283 shares in the last quarter. Herald Investment Management Ltd lifted its position in shares of UiPath by 85.4% during the first quarter. Herald Investment Management Ltd now owns 161,280 shares of the company's stock worth $1,660,000 after purchasing an additional 74,280 shares in the last quarter. National Bank of Canada FI acquired a new position in shares of UiPath during the first quarter worth approximately $72,000. Finally, Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in shares of UiPath by 62.9% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 82,871 shares of the company's stock worth $854,000 after purchasing an additional 32,013 shares in the last quarter. 62.50% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In other UiPath news, CEO Daniel Dines sold 9,988 shares of the company's stock in a transaction that occurred on Thursday, July 31st. The shares were sold at an average price of $12.00, for a total value of $119,856.00. Following the completion of the sale, the chief executive officer owned 4,598,388 shares of the company's stock, valued at approximately $55,180,656. This represents a 0.22% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders have sold a total of 831,310 shares of company stock valued at $10,428,922 over the last ninety days. 23.19% of the stock is currently owned by corporate insiders.
UiPath Trading Down 1.3%
Shares of PATH traded down $0.14 on Monday, reaching $11.03. 8,047,036 shares of the company's stock were exchanged, compared to its average volume of 11,593,855. The stock has a market capitalization of $5.90 billion, a P/E ratio of -91.91, a price-to-earnings-growth ratio of 14.63 and a beta of 1.03. The business has a 50 day moving average price of $12.04 and a two-hundred day moving average price of $12.04. UiPath, Inc. has a 12 month low of $9.38 and a 12 month high of $15.93.
UiPath (NYSE:PATH - Get Free Report) last posted its quarterly earnings results on Thursday, May 29th. The company reported $0.11 earnings per share for the quarter, topping analysts' consensus estimates of $0.10 by $0.01. The business had revenue of $356.62 million during the quarter, compared to the consensus estimate of $332.17 million. UiPath had a negative net margin of 4.65% and a negative return on equity of 3.05%. UiPath's revenue for the quarter was up 6.4% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.13 earnings per share. UiPath has set its Q2 2026 guidance at EPS. FY 2026 guidance at EPS. Equities research analysts predict that UiPath, Inc. will post -0.17 EPS for the current year.
Analyst Upgrades and Downgrades
A number of equities analysts have recently issued reports on PATH shares. Evercore ISI upped their target price on shares of UiPath from $11.00 to $15.00 and gave the stock an "in-line" rating in a research report on Friday, May 30th. Zacks Research upgraded shares of UiPath to a "hold" rating in a research report on Friday, August 8th. Scotiabank upped their target price on shares of UiPath from $12.00 to $13.00 and gave the stock a "sector perform" rating in a research report on Friday, May 30th. Barclays reiterated an "equal weight" rating on shares of UiPath in a research report on Friday, May 30th. Finally, Royal Bank Of Canada upped their target price on shares of UiPath from $13.00 to $15.00 and gave the stock a "sector perform" rating in a research report on Friday, May 30th. Two equities research analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat, UiPath has a consensus rating of "Hold" and an average target price of $13.83.
View Our Latest Report on PATH
About UiPath
(
Free Report)
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Featured Stories

Before you consider UiPath, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UiPath wasn't on the list.
While UiPath currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.